Effect of insulin on weight loss and tumour growth in a cachexia model. by Beck, S. A. & Tisdale, M. J.
B e9 The Macmillan Press Ltd., 1989
Effect of insulin on weight loss and tumour growth in a cachexia
model
S.A. Beck & M.J. Tisdale
CRC Experimental Chemotherapy Group, Pharmaceutical Sciences Institute, Aston University, Birmingham B4 7ET, UK.
Summary A comparison has been made between the effects of daily insulin injection and a ketogenic diet on
weight loss and tumour weight in an experimental model of cancer cachexia (MAC16). Weight loss associated
with the MAC16 tumour was significantly reduced both by a ketogenic diet (80% MCT) and by daily insulin
injections without an increase in either food or water consumption. Animals fed the 80% MCT diet had a
significantly reduced tumour weight compared with controls fed a normal laboratory diet, while in animals
administered 20 U insulin kg- 1 day-1 the tumour weight was 50% greater than in saline infused controls. The
stimulation of tumour growth by insulin was counteracted by the inclusion of 3-hydroxybutyrate in the
drinking water without any alteration in the extent of weight loss. Depletion of both carcass fat and muscle
dry weight in animals bearing the MAC16 tumour was reversed in animals administered either insulin or an
80% MCT diet. Animals bearing the MAC16 tumour had a reduced nitrogen balance compared wth non-
tumour-bearing controls, mainly due to excess urea excretion, and this was reversed towards control values in
animals fed an 80% MCT diet, but not in animals administered insulin. These results suggest that a ketogenic
diet is more effective than insulin administration in reversing the cachectic process and has the advantage of a
concomitant reduction in tumour weight.
One of the characteristics of cancer cachexia is an
accelerated weight loss, which results in a depletion not only
of the host adipose tissue, but also of total body protein.
Although the frequency of weight loss varies with tumour
type, 54% of patients with disseminated cancer had lost
some weight at the time of presentation (De Wys et al.,
1980). Cachexia is responsible for the severe morbidity and
mortality in cancer patients and for a decreased tolerance to
cancer treatment (De Wys et al., 1980; Rivlin et al., 1983;
Heber et al., 1986). Provision of excess calories alone does
not appear to change median survival in patients with
advanced cancer and many patients either maintain body
weight or lose weight while receiving calories which would be
predicted to result in weight gain (Heber et al., 1986).
Concern has been expressed that nutritional support may
cause nutritional stimulation of tumour growth in those
patients who fail to respond to anticancer therapy (Nixon et
al., 1981).
As an experimental model of cachexia we have
investigated a transplantable mouse colon adenocarcinoma
(MAC16), which produces up to 40% weight loss in
recipient animals at tumour burdens of only 2-3% without a
reduction in caloric intake (Bibby et al., 1987; Beck &
Tisdale, 1987). Weight loss produced by the MAC16 tumour
is associated with the presence of circulatory catabolic
factors which cause an enhanced triglyceride breakdown in
adipocytes and amino acid release from diaphragm in vitro
(Beck & Tisdale, 1987). The activity of the tumour catabolic
factors is inhibited by both insulin and 3-hydroxybutyrate
and completely abolished by a mixture of the two. Using an
isocaloric, isonitrogenous ketogenic diet we have shown a
reduction in host weight loss produced by the MAC16
tumour with a concomitant reduction in tumour weight
(Tisdale et al., 1987). Insulin has anabolic effects, which are
opposite to the catabolic effects of the tumour, and has been
suggested as a possible supportive measure in the total
nutritional management of the cancer patient (Schein et al.,
1979). In rats bearing a transplantable sarcoma insulin has
been shown to cause a significant enhancement of host
weight and food intake, while not affecting tumour growth
(Moley et al., 1985). In this study the effects of daily insulin
administration on host and tumour weight has been
investigated in the MAC16 cachexia model.
Received 19 July 1988, and in revised form, 10 December 1988.
Materials and methods
Pure strain male NMRI mice (age 12-15 weeks) were
purchased from Banting and Kingman (Hull, UK) and were
fed rat and mouse breeding diet (Pilsbury, Birmingham, UK)
and water ad libitum. The standard diet contained 50%
carbohydrate and supplied 11.5% of the energy as fat.
Fragments of the MAC16 tumour were implanted into the
flank by means of a trocar as described (Bibby et al., 1987)
and were given free access to rat and mouse breeding diet
after transplantation until weight loss occurred, when they
were randomised as described below. Blood was removed
using a heparised syringe by cardiac puncture from animals
under anaesthesia with a mixture of halothane, oxygen and
nitrous oxide without subsequent survival. Plasma was
prepared by centrifuging whole blood in a Beckman
microfuge for 30 s. Isophane insulin was supplied by Evans
Medical Ltd (Greenford, Middlesex, UK).
Insulin administration
When the tumours became palpable and the animals started
to lose weight (14-21 days after transplantation) they were
randomised into six groups, five of which continued to
receive the rat and mouse breeding diet and water ad libitum.
One group served as control and was injected s.c. in the leg
daily with 200/tl of 0.9% NaCl. A second group was
injected daily with 15 U insulin kg-I day-I and two groups
were injected daily with 20 U insulin kg-1 day-1. All insulin
injections were administered in a volume of 200jMI of 0.9%
NaCl between 10 and 11 a.m. for an 8-day period. One of
the groups receiving 20 U insulin kg-1 day- 1 was given
sodium D(-)-3-hydroxybutyrate in the drinking water at a
concentration of 30 pmolml-1 and another group received
D(-)-3-hydroxybutyrate alone. The average daily water
consumption for all groups did not differ significantly and is
indicated in Table I.
A fifth group of animals received a diet which was
isonitrogenous and isocaloric to the rat and mouse breeding
diet, and which supplied 80% of the calories as medium
chain triglyceride (MCT) and was supplemented with rodent
006 premix (Tisdale et al., 1987). This diet was formulated as
a paste to minimise food scatter. All food was supplied ad
libitum. Two control groups of non-tumour-bearing animals
of the same body weight received daily injections of either
0.9% NaCl or 20 U insulin kg -I day- . Body weights and
food and water intake were measured daily during the course
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of the study and food scatter was subtracted. Body weights
were measured at the same time of day. After 8 days the
mice were put into metabolic cages (Jencons, Hemel
Hempstead, Herts, UK) and a 24h urine collection was
carried out. Faeces was collected for nitrogen analysis. Blood
was removed by cardiac puncture between 10 and 11 a.m. on
day 9.
Metabolite assays
Whole blood (0.2 ml) was used and glucose was determined
using the o-toluidine reagent kit (Sigma). Free fatty acid
(FFA) levels were determined by a Wako NEFA C kit
(Alpha Laboratories Ltd, Hampshire, UK). Acetoacetate
and 3-hydroxybutyrate levels were measured by the methods
of Mellanby & Williamson (1974) and Williamson &
Mellanby (1974) respectively. Ammonia, urea and creatinine
in urine were analysed quantitatively using Sigma diagnostic
kits (Sigma Chemical Co., Dorset, UK).
Body composition analysis
Each carcass was placed in an oven at 80°C until constant
weight was reached. Carcasses were then reweighed and the
total fat content was determined by the method of
Lundholm et al. (1980). The residue was the non-fat mass.
The thigh plus gastrocnemius muscle dry weights were also
determined.
Statistical analysis
The results were analysed statistically using the analysis of
variance.
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Results
The effect of daily insulin injection on the food intake,
degree of weight loss and tumour weight in male NMRI
mice bearing the MAC16 adenocarcinoma is shown in Table
I. Non-tumour-bearing animals injected with insulin at the
maximum concentration of 20 U kg 1 day-1 had no
significant alteration in either food intake or body weight
gain when compared with animals injected with 0.9% NaCl
alone. Animals bearing the MAC16 tumour had a highly
significant decrease in body weight when treated with 0.9%
NaCl alone without an alteration in food or water intake,
and this weight loss was significantly reduced either by
feeding a diet in which 80% of the calories were supplied as
MCT or by insulin injection (20 Ukg 1 day-1), with or
without supplementation with D(-)-3-hydroxybutyrate in the
drinking water. Prevention of weight loss in animals fed
either an 80% MCT diet or administered insulin occurred
without a significant alteration in food consumption (Table
I), determined by analysis of variance. The extent of weight
loss with lower concentrations of insulin (15 U kg- day-1)
was not significantly different from controls. The prevention
of weight loss by the 80% MCT diet was associated with a
significant reduction in tumour weight, while in animals
administered 20 U insulinkg-1 day-1 the tumour weight was
50% greater than in tumour-bearing animals administered
0.9% NaCl (P<0.05). This stimulation of tumour growth
rate by insulin was counteracted by the inclusion of D(-)-3-
hydroxybutyrate in the drinking water without any effect on
the extent of weight loss. Animals administered 3-hydroxy-
butyrate alone had a weight loss and tumour growth rate
similar to those administered 0.9% NaCl.
The total carcass fat and the thigh plus gastrocnemius
muscle dry weights from the animals in each of the dietary
groups are shown in Table II. Animals bearing the MAC16
tumour had a large reduction in carcass fat when compared
with non-tumour-bearing animals. This reduction in carcass
fat produced by the MAC16 tumour was reversed in animals
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fed either the 80% MCT diet or administered insulin daily
but not in those administered 3-hydroxybutyrate alone. The
thigh plus gastrocnemius muscle dry weights were also
significantly reduced in tumour-bearing animals fed the
normal diet, and this was reversed towards control values in
animals administered insulin.
The plasma level of metabolites in each of the dietary
groups is shown in Table III. As previously reported (Bibby
et al., 1987) mice bearing the MAC16 tumour have a
significantly reduced blood glucose level and the hypoglycae-
mia is maintained in animals administered insulin. Plasma
levels of FFA, which are reduced in tumour-bearing animals,
are not altered by insulin, but are elevated in animals fed the
80% MCT diet or given supplementary 3-hydroxybutyrate.
Plasma levels of acetoacetate or 3-hydroxybutyrate are not
elevated in tumour-bearing animals fed the normal diet
despite the large depletion of carcass fat (Table II). While
insulin alone had no effect on the plasma levels of acetoace-
tate or 3-hydroxybutyrate, the inclusion of 3-hydroxy-
butyrate in the drinking water, or changing the diet to 80%
MCT, caused a significant elevation in the plasma levels of
both ketone bodies.
The effect of dietary modification and insulin injection on
the nitrogen balance and urinary nitrogen excretion is shown
in Table IV. Nitrogen excretion in the faeces is not signifi-
cantly different in animals bearing the MAC16 tumour from
that in non-tumour-bearing animals. Animals bearing the
MAC16 tumour had a similar nitrogen input but a signifi-
cantly greater nitrogen output than non-tumour-bearing
controls. The major contribution to the nitrogen output was
urinary urea, which was significantly elevated in tumour-
bearing animals fed a normal diet, suggesting an increased
gluconeogenesis from amino acids. Tumour-bearing animals
fed an 80% MCT diet had a nitrogen intake which was not
significantly different from those fed a normal diet, but the
nitrogen output was significantly reduced such that the
nitrogen balance was not significantly different from that of
non-tumour-bearing controls. Urinary urea excretion was
also significantly reduced in tumour-bearing animals fed the
80% MCT diet suggesting a reduction in gluconeogenesis
from amino acids. Although the total nitrogen output was
significantly reduced in tumour-bearing animals administered
20 U insulin kg-1 day-1, and the urinary urea excretion was
significantly reduced from tumour-bearing animals adminis-
tered 0.9%, the nitrogen balance was not significantly ele-
vated above saline infused controls. Urinary ammonia levels
were significantly elevated only in animals given sodium 3-
hydroxybutyrate in their drinking water due to the excretion
of keto acids in the urine (total concentration
0.23mg24h1)h
Discussion
Plasma levels of immunoreactive insulin have been reported
to be decreased and glucagon increased in tumour-bearing
animals (Chance et al., 1983) and insulin administration has
been reported to decrease host catabolism while not stimu-
lating tumour growth (Chance et al., 1986; Moley et al.,
1985). In fact a number of tumours have been reported to
grow faster in diabetic animals (Hissin & Hilf, 1978; Sauer &
Dauchy, 1987). However, insulin is a known stimulator of
cell growth and in high concentration is a vital component
for the growth of cells in serum-free medium (Barnes &
Sato, 1980). Like many other growth factors the insulin
receptor has tyrosine phosphokinase activity and undergoes
autophosphorylation (Cobb & Rosen, 1984). In this study
we have compared the ability ofinsulin injection, with or with-
out D(-)-3-hydroxybutyrate supplementation to prevent host
weight loss and to conserve lean body tissue without stimu-
lating tumour growth rate. Both insulin and D(-)-3-
hydroxybutyrate are effective inhibitors of the MAC16
tumour-produced lipolytic and proteolytic factors and thus
Table II Total carcass fat and thigh plus gastrocnemius muscle dry weights after
insulin injection or dietary modification
Carcass fat Muscle dry weight
Tumour Treatment (g) (g)
None 0.9% NaCl s.c. 1.70 +0.09b 0.090+0.003C
None 20 U insulin kg-' day-1 s.c. 1.64+0.10b 0.098+0.005a
MAC16 0.9% NaCl s.c. 0.58+0.11 0.070+0.002
MAC16 80% MCT diet 1.00+0.17a 0.080+0.003
MAC16 15 U insulin kg-' day-' s.c. 1.07+0.11a 0.083+0.003a
MAC16 20 U insulin kg-1 day-1 s.c. 1.00+0.10a 0.080+0.002
MAC16 20 U insulin kg-1 day-' s.c.
+3-hydroxybutyrate 0.92+0.13 0.075+0.004
MAC16 3-hydroxybutyrate 0.65+0.12 0.070+0.003
Results are expressed as mean+s.e.m. for six to 12 animals per group. ap<0.05
from MAC16 tumour-bearing animals injected with 0.9% NaCl. bp<0.00001 from
MAC16 tumour-bearing animals injected with 0.9% NaCl. CP<0.0004 from MAC16
tumour-bearing animals injected with 0.9% NaCl.
Table III Effect of insulin injection and dietary modification on plasma metabolite levels
Glucose FFA Acetoacetate 3-Hydroxybutyrate
Tumour Treatment (mM) (mM) (PM) (#M)
None 0.9% NaCl s.c. 6.76+0.24 1.01+0.06 40+4 105+19
None 20 U insulin kg- 1 day-1 7.57+0.24 0.72+0.07 37+8 92+28
MAC16 0.9% NaCl s.c. 5.52+0.43a 0.36+0.020 34+6 70+14
MAC16 80% MCT diet 5.60+0.36a 0.48+0.09cd 74+7e 241 +22f
MAC16 15 U insulin kg-' day-1 4.37+0.49b 0.42+0.11c - -
MAC16 20 U insulin kg-' day-1 4.22+0.76b 0.43+0.11c 39+8 81+19
MAC16 20 U insulin kg-' day-'
+3-hydroxybutyrate 4.10+0.18b 0.49+0.06c d 83 +6C 265 +30O
MAC16 3-hydroxybutyrate 4.76+0.42a 0.41 +0.07c 101 + toe 122+29' y~~~~~~~~~~~~~~~~~~~~~~~~~~
Results are expressed as mean+ s.e.m. for six to 12 animals per group. ap<0.025 from non-tumour-bearing
animals. bp<0.001 from non-tumour-bearing animals. CP<0.0001 from non-tumour bearing animals. dp<0.05
from tumour-bearing animals injected with 0.9), NaCl. CP<0.002 from tumour-bearing animals injected with
0.9%NaCl. fP<0.0005 from tumour-bearing animals injected with 0.9%NaCl.680 S.A. BECK & M.J. TISDALE
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are considered as good candidates as anticachectic agents
(Beck & Tisdale, 1987).
Insulin administered daily at a concentration of 20 U kg 1
has been shown to be as effective as a ketogenic diet in the
prevention of weight loss induced by the MAC16 tumour.
However, whereas an 80% MCT diet leads to a significant
reduction in tumour weight, insulin causes an enhanced
tumour growth rate. The stimulatory effect of insulin on
tumour growth is abolished by the continuous adminis-
tration of sodium D(-)-3-hydroxybutyrate in the drinking
water suggesting that 3-hydroxybutyrate has the ability to
block the insulin mediated stimulation of tumour growth
since 3-hydroxybutyrate alone has no effect on either weight
loss or tumour growth. The anticachectic effect of insulin
and a ketogenic diet is mediated without an increase in food
consumption and animals bearing the MAC16 tumour show
weight loss without a reduction in food intake, suggesting
that anorexia is not responsible for weight loss in this model
system (Bibby et al., 1987). Previous workers have demon-
strated a potent anticachectic effect of exogenous insulin
which was attributed to a stimulation of food intake and
occurred without an effect on tumour growth (Moley et al.,
1985; Chance et al., 1986), although recent work suggests an
increased tumour weight in insulin treated animals (Moley et
al., 1988). However, insulin has the capacity to increase
substrate availability, which may be important in the insulin
induced growth stimulation. Certainly blood glucose levels
are somewhat lower in the presence of insulin.
Both the carcass fat and the thigh and gastrocnemius
muscle mass are preserved to some extent in MAC16
tumour-bearing animals administered either insulin or an
80% MCT diet. Both insulin and 3-hydroxybutyrate inhibit
lipase activation in adipose tissue (Bjorntorp, 1966) and
insulin has been shown to stimulate protein synthesis and
inhibit protein degradation in isolated rat diaphragm (Fulks
et al., 1975) and to reduce the conversion of alanine to
glucose in the liver (Inculet et al., 1987). An increased level
of gluconeogenesis has been observed in cachectic cancer
patients and may contribute to the weight loss (Gold, 1974).
The mechanism by which insulin and 3-hydroxybutyrate
reduce the tumour-produced lipopolytic and proteolytic
activity (Beck & Tisdale, 1987) remains unresolved, but may
be related to their function in normal metabolism.
Increased muscle proteolysis in cachectic animals is evi-
denced by an increased urinary output of nitrogen metabo-
lites, without an alteration of nitrogen input, resulting in a
less positive nitrogen balance. Animals fed the 80% MCT
diet have a reduction in total nitrogen output, without an
effect on nitrogen input, raising the nitrogen balance to that
of non-tumour-bearing controls, while the nitrogen balance
in animals administered insulin is not different from saline
infused controls despite a significant reduction in urea
excretion.
We have recently shown that a ketogenic diet is capable of
inducing significant weight gain in severely cachectic patients
(Fearon et al., 1988). While no information on tumour
growth rate was available from this clinical study we have
previously shown that a similar diet fed to mice bearing a
cachexia-inducing tumour was capable of preventing weight
loss and at the same time reducing tumour burden (Tisdale
et al., 1987). In this comparison with an 80% MCT diet as
anticachectic therapy insulin produced not only an acceler-
ated growth rate, but also occasional unexpected deaths,
presumably due to hypoglycaemia. Moley et al. (1985) also
reported a shortened survival of tumour-bearing animals
receiving long-term insulin therapy, and thus patients would
have to be closely monitored to avoid hypoglycaemic death.
Thus the potential for stimulation of tumour growth and
possible toxicity would make insulin less suitable than a
ketogenic diet as anticachectic therapy.
The authors would like to thank Mr M. Wynter for the tumour
transplantation. SAB gratefully acknowledges the receipt of a
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